The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...

Blood-based biomarkers and imaging measures may help monitor MASH disease activity, potentially reducing reliance on liver biopsies. Semaglutide treatment showed significant improvements in liver ...

Early screening for liver disease in type 2 diabetes is crucial for improving patient outcomes and preventing severe ...

Background: The Prognostic Lung Fibrosis Consortium (PROLIFIC) was formed to develop well-qualified assays suitable for use as prognostic biomarkers within the context of clinical trials for Idiopathic ...

Liver fibrosis and DPN are common complications in T2DM, yet their interrelationship remains underexplored. In this cross-sectional study, 86 T2DM patients with hepatic steatosis underwent DPN ...

Researchers analysed over 9,000 patients using a tool called FibroScan, which measures liver stiffness without needles or ...

Study involving over 9,000 patients, published in The Lancet, found that one in four adults with Type 2 diabetes had ...